Speaker Profile
Ph.D., CEO/CTO & Founder, Giftshed
Biography
Dongyoung Lee is the Founder of Giftshed, developing a whole-blood, single-cell CTC liquid biopsy platform based on next-generation digital microscopy and Vision AI. He previously founded and led Noul through IPO, scaling advanced diagnostics from early innovation to global commercialization.
At Giftshed, he is building an AI-driven liquid biopsy platform that captures the complete cellular landscape of blood, generating large-scale morphological datasets for ultra-rare CTC detection. The system integrates high-throughput imaging with computational analysis to enable single-cell identification for early metastasis research and longitudinal cancer monitoring.
Talk
A Single-Cell CTC Liquid Biopsy Platform Via Next-Gen Microscopy
The session introduces a whole-blood, single-cell CTC liquid biopsy platform combining next-gen digital microscopy with Vision AI. By imaging billions of cells, the system enables AI-based ultra-rare CTC detection and single-cell picking, supporting downstream RNA sequencing and multi-omics analysis while advancing insights into metastatic progression.
Clinical Dx Showcase:
Giftshed Inc.
A whole-blood, single-cell CTC liquid biopsy platform powered by next-gen microscopy and Vision AI, enabling downstream single-cell multi-omics to explore early metastasis biology.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
